1. Das Resistenzproblem bei der Chemo-und Radiotherapie maligner Tumoren;W Achterrath,1984
2. Adamson, R.H., Canellos, G.P., and Sieber, S.M. (1975). Studies on the Antitumor Activity of Gallium Nitrate (NSC 15200) and Other Group Ma Metal Salts. Cancer Chemotherapy Reports (Part 1), 59, 3, 599–610.
3. Alessio, E., Attia, W., Calligaris, M., Cauci, S., Dolzani, L., Mestroni, G., MontiBragadin, C., Nardin, G., Quadrifoglio, F., Sava, G., Tamaro, M., and Zorzet, S. (1988). Metal Complexes of Platinum Group: The Promising Antitumor Features of cisDichlorotetrakis(dimethylsulfoxide)ruthenium(II) [cis-RuC12(MeSO)4] and Related Complexes. In: Nicolini, M. (ed.), Proc. of the 5th Int. Symp. on Platinum and other Metal Coordination Compounds in Cancer Chemotherapy, 617–633, Martinus Nijhoff Publishing, Boston.
4. Alessio, E., Mestroni, G., Nardin, G., Attia, W.M., Calligaris, M., Sava, G., and Zorzet, S. (1988). Cis-and trans-Dihalotetrakis(dimethylsulfoxide)ruthenium(II) Complexes (RuX2(DMSO)4; X = Cl, Br): Synthesis, Structure, and Antitumor Activity. Inorganic Chemistry, 27, 23, 4099–4106.
5. Anghileri, L.J. (1975). On the Antitumor Activity of Gallium and Lanthanides. Arzneim.-Forsch./Drug Res. 25, 5, 793–795.